Zobrazeno 1 - 10
of 59
pro vyhledávání: '"H. N. Sabbah"'
Publikováno v:
Heart failure reviews. 5(2)
An important feature of heart failure is the progressive deterioration of left ventricular function that occurs in the absence of clinically apparent intercurrent adverse events. The mechanism or mechanisms responsible for this hemodynamic deteriorat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7358af8422a66bd2146299714a82b0db
https://pubmed.ncbi.nlm.nih.gov/16228140
https://pubmed.ncbi.nlm.nih.gov/16228140
Autor:
H N, Sabbah
Publikováno v:
Cardiovascular drugs and therapy. 15(6)
Progressive left ventricular (LV) dysfunction is a characteristic feature of the failing heart. The mechanism or mechanisms that drive this progression are not known. In recent years, we advanced a working hypothesis that progressive LV dysfunction i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::903262504cdddb76b5aca075393793d4
https://pubmed.ncbi.nlm.nih.gov/11916361
https://pubmed.ncbi.nlm.nih.gov/11916361
Autor:
H N, Sabbah, W, Haddad, Y, Mika, O, Nass, R, Aviv, V G, Sharov, V, Maltsev, B, Felzen, A I, Undrovinas, S, Goldstein, N, Darvish, S A, Ben-Haim
Publikováno v:
Heart failure reviews. 6(1)
The intravenous use of positive inotropic agents, such as sympathomimetics and phosphodiesterase inhibitors, in heart failure is limited by pro-arrhythmic and positive chronotropic effects. Chronic use of these agents, while eliciting an improvement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c840965f1f9e30e8dbf97b227e4cd22d
https://pubmed.ncbi.nlm.nih.gov/11248767
https://pubmed.ncbi.nlm.nih.gov/11248767
Publikováno v:
Cardiovascular drugs and therapy. 14(1)
The use of positive inotropic agents, such as sympathomimetics and phosphodiesterase inhibitors, in heart failure (HF) is limited by proarrhythmic and positive chronotropic effects. In the present study, we compared the hemodynamic effects of intrave
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::444385b026799be030a553e12351bcd6
https://pubmed.ncbi.nlm.nih.gov/10755204
https://pubmed.ncbi.nlm.nih.gov/10755204
Autor:
H N, Sabbah
Publikováno v:
Clinical cardiology. 22
Enhanced and sustained cardiac adrenergic drive occurs in heart failure (HF) and contributes, in part, to the progression of left ventricular (LV) dysfunction and remodeling that are characteristic of this disease state. Enhanced sympathetic drive in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5413b32f4041091f90bdc409481101c
https://pubmed.ncbi.nlm.nih.gov/10526699
https://pubmed.ncbi.nlm.nih.gov/10526699
Publikováno v:
Annals of medicine. 30
A characteristic feature of heart failure is the progressive deterioration of left ventricular function that occurs in the absence of clinically apparent intercurrent adverse events. The mechanism or mechanisms responsible for this haemodynamic deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0aa0b59f7b43a6063ccf22efb7401f88
https://pubmed.ncbi.nlm.nih.gov/9800881
https://pubmed.ncbi.nlm.nih.gov/9800881
Publikováno v:
Molecular and cellular biochemistry. 187(1-2)
In intact guinea pig ventricles, acetylcholine (ACH) has been shown to attenuate the positive inotropic effects of isobutylmethylxanthine (IBMX), a phosphodiesterase inhibitor, by reducing protein phosphorylation without altering cAMP levels. In the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e5884dc252b8c226a70de261982eb18
https://pubmed.ncbi.nlm.nih.gov/9788753
https://pubmed.ncbi.nlm.nih.gov/9788753
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 285(2)
Despite the marked vasodilator and antiischemic actions of existing calcium channel blockers, their use in the treatment of patients with chronic heart failure (HF) remains highly controversial. We compared the short-term hemodynamic effects of i.v.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa169104f4eae19f65070d850c0d8b00
https://pubmed.ncbi.nlm.nih.gov/9580622
https://pubmed.ncbi.nlm.nih.gov/9580622
Publikováno v:
Pharmacotherapy. 16(3)
To determine and describe relationships between plasma cocaine concentrations and electrophysiologic and electrocardiographic effects, 10 anesthetized dogs with normal intact hearts received a continuous 3-hour infusion of cocaine 0.11 mg/kg/minute (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e6c3efab6bfce3b41a8241751286c52
https://pubmed.ncbi.nlm.nih.gov/8726603
https://pubmed.ncbi.nlm.nih.gov/8726603
Publikováno v:
Pharmacotherapy. 16(3)
We determined the effect of cocaine on ventricular vulnerability to fibrillation, as measured by ventricular fibrillation threshold (VFT), and cardiac electrophysiology in 20 anesthetized dogs with normal hearts. Animals were randomized in blinded fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d7b394614294be0ff05346997b53a1a2
https://pubmed.ncbi.nlm.nih.gov/8726602
https://pubmed.ncbi.nlm.nih.gov/8726602